These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36587174)

  • 1. Corneal cross-linking versus standard care in children with keratoconus - a randomised, multicentre, observer-masked trial of efficacy and safety (KERALINK): a statistical analysis plan.
    Chowdhury K; Doré CJ; Bunce C; Larkin DFP
    Trials; 2020 Jun; 21(1):523. PubMed ID: 32532321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time monitoring of riboflavin concentration using different clinically available ophthalmic formulations for epi-off and epi-on corneal cross-linking.
    Lombardo M; Serrao S; Bernava GM; Mencucci R; Fruschelli M; Lombardo G
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2569-2577. PubMed ID: 38502352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial targeted delivery of riboflavin with a controlled corneal iontophoresis delivery system in theranostic-guided UV-A light photo-therapy.
    Lombardo M; Serrao S; Bernava GM; Lombardo G
    J Biophotonics; 2024 Jul; 17(7):e202400068. PubMed ID: 38697616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early findings in a prospective randomised study on three cross-linking treatment protocols: interruption of the iontophoresis treatment protocol.
    Gustafsson I; Ivarsen A; Hjortdal J
    BMJ Open Ophthalmol; 2023 Sep; 8(1):. PubMed ID: 37739426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic alternatives to riboflavin photochemical corneal cross-linking: a comparison study of cell toxicity thresholds.
    Kim M; Takaoka A; Hoang QV; Trokel SL; Paik DC
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3247-57. PubMed ID: 24722697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and treatment of keratoconus.
    Atalay E; Özalp O; Yıldırım N
    Ther Adv Ophthalmol; 2021; 13():25158414211012796. PubMed ID: 34263132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to design a theranostic trial?
    Siripongsatian D; de Lussanet de la Sablonière QG; Anton Verburg F; Brabander T
    Endocr Oncol; 2024 Jan; 4(1):e230045. PubMed ID: 38770190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction to "Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent".
    Son KH; Lee DS; Park G; Jeon SY; Lee JE; Jeon HJ; Lee S; Park WJ; Shin Y; Kim SG; Lee DS; Han YR; Kim DS; Jeon YH
    ACS Appl Mater Interfaces; 2024 Apr; 16(13):17062. PubMed ID: 38512298
    [No Abstract]   [Full Text] [Related]  

  • 9. Corneal collagen cross-linking in patients with keratoconus from the Dresden protocol to customized solutions: theoretical basis.
    Caruso C; D'Andrea L; Troisi M; Rinaldi M; Piscopo R; Troisi S; Costagliola C
    Int J Ophthalmol; 2024; 17(5):951-962. PubMed ID: 38766341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Predictive Ability of Theranostics for Corneal Cross-linking in Treating Keratoconus: A Randomized Clinical Trial.
    Roszkowska AM; Scorcia V; Mencucci R; Giannaccare G; Lombardo G; Alunni Fegatelli D; Vestri A; Bifezzi L; Bernava GM; Serrao S; Lombardo M
    Ophthalmology; 2024 Jun; ():. PubMed ID: 38908553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of cornea collagen cross-linking with riboflavin for keratoconus.
    Agrawal V
    Indian J Ophthalmol; 2013 Aug; 61(8):433-4. PubMed ID: 23925332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the technology of corneal cross-linking for keratoconus.
    Lytle G
    Eye Contact Lens; 2014 Nov; 40(6):358-64. PubMed ID: 25320955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial assessing theranostic-guided corneal cross-linking for treating keratoconus: the ARGO protocol.
    Roszkowska AM; Lombardo G; Mencucci R; Scorcia V; Giannaccare G; Vestri A; Alunni Fegatelli D; Bernava GM; Serrao S; Lombardo M
    Int Ophthalmol; 2023 Jul; 43(7):2315-2328. PubMed ID: 36587174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic-guided corneal cross-linking: Preclinical evidence on a new treatment paradigm for keratoconus.
    Lombardo G; Bernava GM; Serrao S; Lombardo M
    J Biophotonics; 2022 Dec; 15(12):e202200218. PubMed ID: 36059083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of customized corneal crosslinking versus standard corneal crosslinking in patients with progressive keratoconus (C-CROSS study): study protocol for a randomized controlled trial.
    Vandevenne MMS; Berendschot TTJM; Winkens B; van den Biggelaar FJHM; Visser N; Dickman MM; Wisse RPL; Wijdh RHJ; Roy AS; Shetty R; Nuijts RMMA
    BMC Ophthalmol; 2023 May; 23(1):224. PubMed ID: 37208674
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.